Skip to main content
Michael J. Moss
No Rating Available
(Learn About Our Rating System)

Michael J. Moss, MD, FAACT

Languages spoken: English

Clinical Locations

University of Utah Hospital

Emergency Medicine
Salt Lake City
801-585-9397
  • Dr. Moss is triple board-certified in medical toxicology, addiction medicine, and emergency medicine.

    He serves as the medical director of the Utah Poison Control Center. The poison center hosts learners from a variety of disciplines including pharmacy students, pharmacy residents, emergency medicine residents, and a variety of other medical specialty residents.

    He provides inpatient consultation on toxicology patients at the University of Utah and Primary Children's Hospital and works in the University of Utah Hospital Emergency Department.

    He also provides inpatient consultation on addiction medicine (opioid use disorder, medication assisted treatment, alcohol withdrawal, etc.) at the University Hospital.

    For toxicology consultation please contact the Utah Poison Control Center at 1-800-222-1222.

    Board Certification

    American Board of Emergency Medicine (Emergency Medicine)
    American Board of Emergency Medicine (Sub: Medical Toxicology)
    American Board of Preventive Medicine (Addiction Medicine)
  • Dr. Moss is triple board-certified in medical toxicology, addiction medicine, and emergency medicine.

    He serves as the medical director of the Utah Poison Control Center. The poison center hosts learners from a variety of disciplines including pharmacy students, pharmacy residents, emergency medicine residents, and a variety of other medical specialty residents.

    He provides inpatient consultation on toxicology patients at the University of Utah and Primary Children's Hospital and works in the University of Utah Hospital Emergency Department.

    He also provides inpatient consultation on addiction medicine (opioid use disorder, medication assisted treatment, alcohol withdrawal, etc.) at the University Hospital.

    For toxicology consultation please contact the Utah Poison Control Center at 1-800-222-1222.

    Board Certification and Academic Information

    Academic Departments Eccles Health Library -Primary
    Pharmacotherapy -Adjunct
    Academic Divisions Adult Psychiatry
    Board Certification
    American Board of Emergency Medicine (Emergency Medicine)
    American Board of Emergency Medicine (Sub: Medical Toxicology)
    American Board of Preventive Medicine (Addiction Medicine)

    Education history

    Fellowship Medical Toxicology - Oregon Health & Science University Fellow
    Chief Resident Emergency Medicine - Virginia Commonwealth University School of Medicine Chief Resident
    Residency Emergency Medicine - Virginia Commonwealth University School of Medicine Resident
    Professional Medical Medicine - Ohio State University College of Medicine M.D.
    Undergraduate Physiology and Developmental Biology - Brigham Young University B.S.

    Selected Publications

    Journal Article

    1. Moss MJ, Hinchman B, Lambson JE, Scott JW, Hinckley P, Wylie SJ, Dorey A (2024). Assessment of high-dose acetylcysteine in acute high-risk paracetamol (acetaminophen) ingestion. Clin Toxicol (Phila), 1-7. (Read full article)
    2. Huntbach W, Moss M (2024). Rapid availability of ethylene glycol test results with enzymatic assay. Clin Toxicol (Phila), 1-3. (Read full article)
    3. Rianprakaisang TN, Moss MJ, Gerona R, Hendrickson RG (2023). Plasma concentrations of phenibut and mitragynine in a single patient. Clin Toxicol (Phila), 1-2. (Read full article)
    4. Eisenberg J, Tedford NJ, Weaver N, Becker S, Moss MJ (2023). Adverse Outcomes in Topical Lidocaine Exposure: A Pediatric Case Series From the United States National Poison Data System. Clin Pediatr (Phila), 62(11), 99228231159646. (Read full article)
    5. Moss MJ, Bushlin I, Kazmierczak S, Koop D, Hendrickson RG, Zuckerman KE, Grigsby TM (2021). Cannabis use and measurement of cannabinoids in plasma and breast milk of breastfeeding mothers. Pediatr Res. (Read full article)
    6. Giannouchos TV, Biskupiak J, Moss MJ, Brixner D, Andreyeva E, Ukert B (2020). Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system. Am J Emerg Med, 40, 20-26. (Read full article)
    7. Grigsby TM, Hoffmann LM, Moss MJ (2020). Marijuana Use and Potential Implications of Marijuana Legalization. Pediatr Rev, 41(2), 61-72. (Read full article)
    8. Moss MJ, Hendrickson RG, Toxicology Investigators Consortium ToxIC (2019). Serotonin Toxicity: Associated Agents and Clinical Characteristics. J Clin Psychopharmacol, 39(6), 628-633. (Read full article)
    9. Amirshahi MM, Moss MJ, Smith SW, Nelson LS, Stolbach AI (4/4/2019). ACMT Position Statement: Addressing Pediatric Cannabis Exposure. J Med Toxicol, 15(3), 212-214.
    10. Moss MJ, Fisher JA, Kenny TA, Palmer AC, Thompson JA, Wolfer H, Hendrickson RG (2019). Salicylate toxicity after undetectable serum salicylate concentration: a retrospective cohort study. Clin Toxicol (Phila), 57(2), 137-140. (Read full article)
    11. Moss MJ, Hendrickson RG (2019). Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002-2016. Clin Toxicol (Phila), 57(2), 99-103. (Read full article)
    12. Moss MJ, Warrick BJ, Nelson LS, McKay CA, Dub PA, Gosselin S, Palmer RB, Stolbach AI (2018). ACMT and AACT position statement: preventing occupational fentanyl and fentanyl analog exposure to emergency responders. Clin Toxicol (Phila), 56(4), 297-300. (Read full article)
    13. Moss MJ, Maskell KF, Hieger MA, Wills BK, Cumpston KL (2017). An algorithm for identifying mothball composition. Clin Toxicol (Phila), 55(8), 919-921. (Read full article)
    14. Hieger MA, Maskell KF, Moss MJ, Powell SW, Cumpston KL (2017). Dofetilide in Overdose: A Case Series from Poison Center Data. Cardiovasc Toxicol, 17(3), 368-371. (Read full article)

    Case Report

    1. Rodriguez SA, Moss MJ (2020). Pediatric brexpiprazole toxicity. Clin Toxicol (Phila), 58(12), 1354-1355. (Read full article)
    2. Wolf CE, Poklis JL, Cumpston K, Moss M, Poklis A (2017). Acute dilated cardiomyopathy and myocardial injury after combined 4-fluoroamphetamine and modafinil ingestion. Drug Test Anal, 9(4), 657-659. (Read full article)

    Letter

    1. Moss MJ (2019). Salicylate toxicity from ingestion of an oil of wintergreen containing insecticide. [Letter to the editor]. Clin Toxicol (Phila), 58(3), 219-220. (Read full article)

    Video/Film/CD/Web/Podcast

    1. Teemant K, Crouch BI, Bennet H, Rhien T, Moss M (2019). Naloxone 101 Training. [Web]. Utah Department of Health.